ANG Lifesciences India Beneish M-Score Historical Data
The historical data trend for ANG Lifesciences India's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANG Lifesciences India Beneish M-Score Chart
|
ANG Lifesciences India Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-2.34 |
-1.94 |
-0.56 |
-1.40 |
-3.00 |
|
ANG Lifesciences India Quarterly Data
|
|
Sep17 |
Mar18 |
Sep18 |
Mar19 |
Sep19 |
Mar20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
-3.00 |
- |
- |
- |
Competitive Comparison of ANG Lifesciences India's Beneish M-Score
For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANG Lifesciences India's Beneish M-Score Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where ANG Lifesciences India's Beneish M-Score falls into.
ANG Lifesciences India Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of ANG Lifesciences India for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 1.3227 | + | 0.528 * 1.1315 | + | 0.404 * 0.8655 | + | 0.892 * 0.6206 | + | 0.115 * 0.6218 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0.9501 | + | 4.679 * -0.095241 | - | 0.327 * 1.025 |
| = | -3.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Mar23) TTM: | Last Year (Mar22) TTM: |
Total Receivables was ₹847 Mil.
Revenue was ₹2,198 Mil.
Gross Profit was ₹692 Mil.
Total Current Assets was ₹1,869 Mil.
Total Assets was ₹2,797 Mil.
Property, Plant and Equipment(Net PPE) was ₹881 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹94 Mil.
Selling, General, & Admin. Expense(SGA) was ₹49 Mil.
Total Current Liabilities was ₹1,623 Mil.
Long-Term Debt & Capital Lease Obligation was ₹228 Mil.
Net Income was ₹-3 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹264 Mil.
|
Total Receivables was ₹1,031 Mil.
Revenue was ₹3,541 Mil.
Gross Profit was ₹1,261 Mil.
Total Current Assets was ₹1,928 Mil.
Total Assets was ₹2,910 Mil.
Property, Plant and Equipment(Net PPE) was ₹926 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹59 Mil.
Selling, General, & Admin. Expense(SGA) was ₹84 Mil.
Total Current Liabilities was ₹1,663 Mil.
Long-Term Debt & Capital Lease Obligation was ₹216 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (846.669 / 2197.783) | / | (1031.367 / 3541.245) |
| = | 0.385238 | / | 0.291244 |
| | = | 1.3227 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (1261.424 / 3541.245) | / | (691.886 / 2197.783) |
| = | 0.356209 | / | 0.314811 |
| | = | 1.1315 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (1868.935 + 881.478) / 2797.029) | / | (1 - (1928.121 + 926.145) / 2910.304) |
| = | 0.016666 | / | 0.019255 |
| | = | 0.8655 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 2197.783 | / | 3541.245 |
| | = | 0.6206 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (58.752 / (58.752 + 926.145)) | / | (93.535 / (93.535 + 881.478)) |
| = | 0.059653 | / | 0.095932 |
| | = | 0.6218 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (49.471 / 2197.783) | / | (83.903 / 3541.245) |
| = | 0.02251 | / | 0.023693 |
| | = | 0.9501 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((228.409 + 1622.84) / 2797.029) | / | ((216.37 + 1662.893) / 2910.304) |
| = | 0.661863 | / | 0.645727 |
| | = | 1.025 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (-2.621 - 0 | - | 263.772) | / | 2797.029 |
| | = | -0.095241 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
ANG Lifesciences India has a M-score of -3.00 suggests that the company is unlikely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:540694 has been successfully added to your